Matching slides 16,285
Current window 7,081-7,110
Pages 543
Rows per page 30
Tool: Table Dataclear collectionreset all

Tool

7,081-7,110 of 16,285

filter-aware
44
Includes footnotes (a) through (h) and specific pro forma earnings per share data.AlTi | Investor Presentation Deck | 46 slides · Alvarium Tiedemann
Pitch deck Investor relations 1 hit
32
Includes footnotes 1-4 explaining specific line items.Apollo Global Management | Investor Presentation Deck | 38 slides · Apollo Global Management
Conference presentation Investor relations 1 hit
33
The table provides a detailed breakdown of adjustments including equity-based compensation, unrealized performance fees, and tax-related items.Apollo Global Management | Investor Presentation Deck | 38 slides · Apollo Global Management
Conference presentation Investor relations 1 hit
30
The table includes footnotes for specific funds and a general note on inclusion criteria.Apollo Global Management | Results Presentation Deck | 44 slides · Apollo Global Management
Conference presentation Investor relations Beat · Action1 hit
31
Includes extensive footnotes explaining fund vintage, IRR calculation methodology, and currency translation adjustments.Apollo Global Management | Results Presentation Deck | 44 slides · Apollo Global Management
Conference presentation Investor relations Beat · Action1 hit
32
The slide displays a significant increase in total assets, primarily driven by the inclusion of Retirement Services data in 3Q'22.Apollo Global Management | Results Presentation Deck | 44 slides · Apollo Global Management
Conference presentation Investor relations Beat · Action1 hit
33
The slide presents financial data in millions of dollars, comparing two reporting periods.Apollo Global Management | Results Presentation Deck | 44 slides · Apollo Global Management
Conference presentation Investor relations Beat · Action1 hit
34
Includes footnotes detailing specific adjustments like equity-based profit sharing and merger-related costs.Apollo Global Management | Results Presentation Deck | 44 slides · Apollo Global Management
Conference presentation Investor relations Beat · Action1 hit
35
Includes footnotes explaining specific adjustments like equity-based profit sharing and transaction-related charges.Apollo Global Management | Results Presentation Deck | 44 slides · Apollo Global Management
Conference presentation Investor relations Beat · Action1 hit
37
The table shows adjustments for investment gains/losses, reinsurance, and other non-operating items.Apollo Global Management | Results Presentation Deck | 44 slides · Apollo Global Management
Conference presentation Investor relations Beat · Action1 hit
38
This is a continuation slide for financial disclosures.Apollo Global Management | Results Presentation Deck | 44 slides · Apollo Global Management
Conference presentation Investor relations Beat · Action1 hit
38
The slide compares product revenue (stacked bar) with collaboration revenue (stacked bar) for the drug Lynparza.AstraZeneca | Results Presentation Deck | 44 slides · AstraZeneca
Conference presentation Investor relations 1 hit
06
The slide uses a Gantt-style visualization to represent the clinical development status of multiple drug candidates.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
17
The slide includes detailed footnotes explaining the specific adjustments made to Net Income to arrive at Adjusted EBITDA.Azek | Results Presentation Deck | 20 slides · The AZEK Company
Conference presentation Investor relations 1 hit
33
The slide uses a comparison table to highlight the strategic rationale behind specific M&A activities.Azerion | Investor Presentation Deck | 45 slides · Azerion
Pitch deck Investor relations 1 hit
45
The slide uses a feature-comparison matrix to differentiate between service tiers.Azerion | Investor Presentation Deck | 45 slides · Azerion
Pitch deck Investor relations 1 hit
12
The slide uses a combination of bar charts and donut charts to visualize revenue performance and segment composition.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
13
The table is split into two main blocks: 3Q performance and YTD performance, with sub-totals for Bausch Pharma + Solta and Bausch + Lomb.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
14
Includes a footnote regarding gain on extinguishment of debt.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
15
Includes constant currency adjustments and detailed footnotes regarding non-GAAP measures.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
16
Includes detailed footnotes regarding restricted cash, debt definitions, and non-GAAP measures.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
17
The slide highlights that there are no significant debt maturities until 2025.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
18
The chart uses a stacked bar format to represent different debt instruments maturing between 2022 and 2031.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
27
The table compares inventory levels at the end of Q2 and Q3 for two consecutive years, calculating the quarterly change.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations 1 hit
28
The table compares inventory levels as of year-end 2020/2021 against September year-to-date figures for 2021/2022.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations 1 hit
30
Includes footnotes regarding non-GAAP measures, share counts, and exclusions for cash flow.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations 1 hit
31
The table provides a breakdown of financial performance by segment, excluding certain corporate costs as noted in the footnote.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations 1 hit
32
Bausch Health Companies | Results Presentation Deck | 48 slidesBausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations 1 hit
33
Includes footnote regarding non-GAAP measures.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations 1 hit
34
Includes Bausch Health logo and page number 34.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations 1 hit